TABLE 1.
Antimicrobial susceptibility profile of the ECO167624 strain
| Antibiotic | MICa (μg/mL) | Interpretation |
|---|---|---|
| AMK | ≤8 | S |
| AMP | >8 | R |
| AMC | >8|4 | R |
| AZT | >4 | R |
| FEP | >8 | R |
| CTX | >16 | R |
| CAZ | >8 | R |
| CIP | >1 | R |
| LEV | >1 | R |
| GNT | >4 | R |
| COL | ≤2 | S |
| FOS | ≤32 | S |
| ERT | >1 | R |
| MER | >8 | R |
| PTZ | >16 | R |
| SXT | >4|76 | R |
| PIP | >16 | R |
| TBR | >4 | R |
a
AMK, amikacin; AMP, ampicillin; AMC, amoxicillin/clavulanate; AZT, aztreonam; FEP, cefepime; CTX, cefotaxime; CAZ, ceftazidime; CIP, ciprofloxacin; LEV, levofloxacin; GNT, gentamicin; COL, colistin; FOS, fosfomycin; ERT, ertapenem; MER, meropenem; PTZ, piperacillin-tazobactam; SXT, trimethoprim-sulfamethoxazole; PIP, piperacillin; TBR, tobramycin; S, susceptible; R, resistant. Susceptibility results were interpreted according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST, 2020) criteria.